Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Accumulated Expenses: 2021-2022

Historic Other Accumulated Expenses for Cullinan Therapeutics (CGEM) over the last 2 years, with Dec 2022 value amounting to $2.0 million.

  • Cullinan Therapeutics' Other Accumulated Expenses rose 100.92% to $2.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.0 million, marking a year-over-year increase of 100.92%. This contributed to the annual value of $2.0 million for FY2022, which is 100.92% up from last year.
  • Per Cullinan Therapeutics' latest filing, its Other Accumulated Expenses stood at $2.0 million for FY2022, which was up 100.92% from $973,000 recorded in FY2021.
  • Over the past 5 years, Cullinan Therapeutics' Other Accumulated Expenses peaked at $2.0 million during FY2022, and registered a low of $973,000 during FY2021.
  • In the last 2 years, Cullinan Therapeutics' Other Accumulated Expenses had a median value of $1.5 million in 2021 and averaged $1.5 million.
  • Data for Cullinan Therapeutics' Other Accumulated Expenses shows a peak YoY spiked of 100.92% (in 2022) over the last 5 years.
  • Yearly analysis of 2 years shows Cullinan Therapeutics' Other Accumulated Expenses stood at $973,000 in 2021, then surged by 100.92% to $2.0 million in 2022.